查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014298

石膏和夾板市場：按產品類型、材料、最終用戶和應用分類 - 2026-2032年全球市場預測

Casting & Splinting Market by Product Type, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，石膏和夾板市場價值將達到 27.5 億美元，到 2026 年將成長到 29.4 億美元，到 2032 年將達到 48 億美元，年複合成長率為 8.25%。

主要市場統計數據
基準年 2025 27.5億美元
預計年份：2026年 29.4億美元
預測年份 2032 48億美元
複合年成長率 (%) 8.25%

為了促進循證決策，我們對影響石膏和夾板固定的臨床、營運和供應鏈趨勢進行了簡潔且權威的概述。

石膏和夾板仍然是整形外科、創傷護理和復健醫學中基本的治療方法。這些治療方法與臨床結果、醫療設備設計和供應鏈趨勢密切相關，並隨著新材料、製造方法和醫療服務模式的出現，以及臨床醫生偏好和患者期望的變化而不斷發展。醫療專業人員尋求兼顧固定效果、重量、滲透性、透光性和易用性的解決方案，而醫療系統則要求器械能夠縮短手術時間並最大限度地減少術後併發症。

臨床重點、材料創新、醫療保健分散化和監管期望如何共同重新定義石膏和夾板固定領域的產品和營運策略。

在石膏和夾板領域，多種因素共同推動變革。臨床上，人們正逐漸傾向於選擇能夠更快應用、提高患者舒適度並更好地與影像學檢查相容的解決方案。這一趨勢促使人們關注合成材料和熱塑性材料，與傳統石膏相比，它們具有更優異的滲透性和更輕的重量。同時，臨床醫生在選擇固定策略時也更加重視在臨床適宜的情況下儘早允許患者活動，這影響著產品的選擇和復健後護理路徑。

對 2025 年關稅政策變化將如何改變石膏和夾板供應鏈中的籌資策略、成本結構和製造決策進行基於證據的評估。

2025年實施的最新關稅措施對石膏和夾板的價值鏈產生了多方面的影響。對某些聚合物組件和成品醫療設備徵收的進口關稅增加了部分製造商和經銷商的收貨成本，促使他們迅速重新檢視籌資策略。對於依賴海外供應商提供熱塑性樹脂、玻璃纖維布和特殊黏合劑的企業而言，這些影響既體現在營運層面，也體現在財務層面。採購團隊已審查了與供應商的契約，合併訂單以實現規模經濟，並探索替代運輸和海關清關方案，以最大限度地減少中斷。

透過對產品類型、材料、醫療保健環境和臨床應用進行實際細分，可以指導優先產品組合開發和商業化。

產品類型的差異化會影響產品的採用趨勢和研發重點。玻璃纖維石膏在強度和重量之間取得了極佳的平衡，而石膏在低成本和可塑性至關重要的場合仍然非常實用。夾板，包括動態夾板和靜態夾板，擴大用於有針對性的固定和復健。合成石膏在特定的臨床場景中提供了快速固化、防水的選擇，而熱塑性石膏則具有可自訂的形狀和更高的舒適度。由於每個產品類型都與特定的臨床工作流程和培訓需求相關，產品組合經理必須使其開發平臺與最快採用這些產品的服務線保持一致。

對當地醫療保健系統、採購慣例和物流現實如何決定產品採用、生產在地化和市場進入策略進行比較分析。

區域差異對產品偏好、監管通路和分銷模式有顯著影響。美洲地區呈現異質性環境，三級醫院系統和門診醫療機構的臨床實務模式各不相同。在採購決策中，服務整合、品質保證以及與經銷商的合約關係往往備受重視。在該地區，人們越來越關注能夠支援快速更換和門診管理的合成材料和熱塑性材料，而在資源有限的環境中，傳統石膏的使用仍然普遍。

產品創新、臨床夥伴關係、製造多元化和價值主導定位如何決定石膏和夾板製造商的競爭優勢。

石膏和夾板行業的主要企業正致力於產品創新、臨床教育和分銷最佳化三者相結合。新型材料配方和預製夾板設計體現了以用戶為中心的理念，即減輕重量、提高透氣性以及與影像技術的兼容性。醫療設備製造商與臨床網路之間的策略合作正在加速推進，重點在於開展培訓項目，以縮短臨床醫生的學習曲線並加快應用速度。

針對製造商、經銷商和醫療保健提供者的具體策略措施，以增強營運穩健性、臨床應用和以價值為導向的商業性成果。

我們將優先發展模組化產品線，使臨床醫生能夠根據特定臨床路徑選擇最合適的材料和應用方案，從而加快採購核准並簡化庫存管理。我們將投資於臨床醫生培訓項目，重點關注應用效率、患者舒適度和基於療效的應用案例，以縮短引進週期並降低應用品質的差異性。改進的品質文件和簡化的監管申報流程將有助於進入多元化的區域市場，並縮短改良材料的上市時間。

我們高度透明、以實踐者為主導的調查方法，結合了對臨床醫生的訪談、技術文獻和供應鏈指標，提供了可操作的見解和檢驗。

本分析整合了第一手和第二手調查數據，以得出以醫療保健專業人員觀點的全面評估。第一手資訊包括對急診、門診和居家照護機構的臨床醫生進行結構化訪談，以了解他們在臨床實踐中的使用偏好、採購決策因素以及培訓不足的領域。第二手調查則納入了關於材料性能的技術文獻和監管指南，以檢驗臨床聲明並促進對產品特性的比較評估。

整合臨床趨勢、供應鏈實際狀況和競爭需求，指導石膏和夾板領域的投資、產品策略和營運決策。

石膏和夾板產業正處於轉折點，材料科學、臨床工作流程的變革以及貿易政策趨勢的交匯融合，重塑著產業的策略選擇。臨床醫生和採購經理必須權衡傳統技術與創新技術，後者可望提升病患體驗和營運效率，同時也要應對日益複雜的供應鏈環境。那些能夠整合臨床醫生培訓、實現供應鏈多元化並為醫療系統創造實際價值的公司，將更有能力影響採購決策並保持成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：石膏與夾板市場：依產品類型分類

  • 玻璃纖維鑄件
  • 石膏模型
  • 夾板
    • 動態夾板
    • 靜態夾板
  • 合成鑄件
  • 熱塑性鑄件

第9章：石膏和夾板市場：依材料分類

  • 玻璃纖維
  • 石膏
  • 熱塑性樹脂
    • 用於高溫的熱塑性樹脂
    • 低溫熱塑性樹脂

第10章：石膏和夾板市場：按最終用戶分類

  • 門診手術中心
  • 居家醫療
  • 醫院
    • 私立醫院
    • 公立醫院
  • 整形外科診所

第11章：石膏與夾板市場：依應用領域分類

  • 正畸模型
  • 斷裂
    • 下肢骨折
    • 上肢骨折
  • 術後固定

第12章：石膏繃帶和夾板市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：石膏與夾板市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：石膏模型與夾板市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國石膏與夾板市場

第16章：中國石膏與夾板市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • AliMed, Inc.
  • Bird & Cronin, Inc.
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Corflex, Inc.
  • DeRoyal Industries, Inc.
  • DJO Global, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, LP
  • Prime Medical, Inc.
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-433AB1DC28B4

The Casting & Splinting Market was valued at USD 2.75 billion in 2025 and is projected to grow to USD 2.94 billion in 2026, with a CAGR of 8.25%, reaching USD 4.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.75 billion
Estimated Year [2026] USD 2.94 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 8.25%

A concise, authoritative framing of clinical, operational, and supply-chain dynamics shaping casting and splinting for evidence-driven decision-making

Casting and splinting remain foundational interventions across orthopedics, trauma care, and rehabilitative medicine. These modalities intersect clinical outcomes, device design, and supply-chain dynamics, and they continue to evolve as new materials, fabrication methods, and care-delivery models alter clinician preferences and patient expectations. Practitioners demand solutions that balance immobilization efficacy with weight, comfort, radiolucency, and ease of application, while health systems seek devices that reduce procedure time and downstream complications.

As pressure mounts on procurement, reimbursement, and operating margins, manufacturers and clinical leaders must coordinate on product innovation, training, and inventory strategies. Technological advances in thermoplastics and synthetic casting systems have introduced alternative application techniques and new sterilization considerations, prompting a reassessment of clinical protocols. Concurrently, ambulatory surgical centers and home healthcare providers are expanding their role in fracture management and postoperative immobilization, necessitating products optimized for decentralized settings.

This introduction sets the stage for a deeper analysis of transformative shifts, policy impacts, segmentation nuances, regional dynamics, competitive activity, and practical recommendations for leaders who must act decisively to maintain clinical relevance and operational resilience in a changing environment.

How clinical priorities, materials innovation, decentralization of care, and regulatory expectations are jointly redefining product and operational strategy in casting and splinting

The casting and splinting landscape is experiencing several converging forces that drive transformation. Clinically, there is a steady migration toward solutions that enable faster application, improved patient comfort, and enhanced imaging compatibility. This trend has increased interest in synthetic and thermoplastic options that offer superior radiolucency and weight reduction compared with traditional plaster. At the same time, clinicians are more selective about immobilization strategies that permit early mobility when clinically appropriate, which affects product selection and post-acute care pathways.

From a manufacturing perspective, materials science innovation has accelerated, with higher-performance thermoplastics and resin systems enabling lighter, more durable constructs and new prefabricated splint designs. Additive manufacturing and digital fitting workflows are beginning to influence custom orthoses and splinting solutions, offering shorter lead times and improved patient fit. These advances challenge legacy supply models and necessitate closer integration between design engineers, clinical educators, and procurement teams.

On the systems side, healthcare delivery is decentralizing; ambulatory surgical centers and home-based care providers are handling a larger share of fracture care and postoperative immobilization, requiring products that simplify training and inventory management. Regulatory emphasis on safety, sterilization, and traceability has intensified, prompting manufacturers to strengthen quality systems and labeling clarity. Taken together, these shifts demand a strategic response from product developers, hospital systems, and distributors to ensure alignment with new clinical workflows and economic pressures.

An evidence-based appraisal of how 2025 tariff policy changes have redirected sourcing strategies, cost structures, and manufacturing decisions in the casting and splinting supply chain

Recent tariff actions in 2025 have had a multifaceted effect on the casting and splinting value chain. Import levies on select polymer components and finished medical devices have raised landed costs for some manufacturers and distributors, prompting rapid reassessment of sourcing strategies. For organizations reliant on overseas suppliers of thermoplastic resins, fiberglass fabrics, and specialized adhesives, the impact has been both operational and financial: procurement teams have revisited supplier contracts, consolidated orders to achieve scale, and explored alternative freight and customs optimization tactics to minimize disruption.

The tariffs have also catalyzed investment decisions. Some manufacturers accelerated plans to localize production or qualify domestic resin and fabric suppliers to reduce exposure to cross-border duties and to improve lead-time reliability. This shift toward nearshoring has implications for capacity planning, capital allocation, and workforce development, as production processes and quality systems are adapted to local regulatory expectations. At the same time, smaller suppliers faced pressure to renegotiate terms or pass cost increases downstream, influencing distributor inventory strategies and clinical purchasing decisions.

Clinicians and hospital procurement leaders responded by emphasizing product standardization and bilateral contracts that lock pricing or provide hedging mechanisms. Payers and health systems scrutinized total cost of care implications, focusing on devices that support reduced length of stay and fewer complications rather than strictly low unit price. Ultimately, the tariffs reinforced the need for supply-chain transparency, material substitution assessments, and scenario planning to preserve service levels and clinical outcomes in an environment of shifting trade policy.

Actionable segmentation insights across product types, materials, care settings, and clinical applications to guide prioritized portfolio development and commercialization

Differentiation across product type influences adoption dynamics and development priorities. Fiberglass casts offer a balance of strength and weight, plaster casts remain relevant where low cost and malleability are paramount, splints-comprising dynamic splints and static splints-are increasingly used for targeted immobilization and rehabilitation, synthetic casts provide rapid-setting, water-resistant alternatives for select clinical scenarios, and thermoplastic casts deliver customizable profiles and improved comfort. Each product category aligns with specific clinical workflows and training needs, so portfolio managers must align development pipelines with the service lines that will adopt them most rapidly.

Material choice shapes manufacturing processes and clinical performance. Fiberglass materials are prized for their tensile strength and radiolucency, plaster of Paris continues to be used where conformability and cost are deciding factors, and thermoplastics-with subdivisions into high temperature and low temperature thermoplastics-enable custom-molding and reusability considerations. The properties of high temperature thermoplastics support durable, semi-permanent orthoses, while low temperature thermoplastics offer convenience for in-clinic molding, influencing decisions about inventory and clinician training.

End-user segmentation reveals divergent procurement behaviors and use cases. Ambulatory surgical centers prioritize speed and predictable device costs as they manage high-throughput procedures. Home healthcare providers emphasize lightweight, patient-friendly solutions that facilitate in-home care and reduce caregiver burden. Hospitals, which include private and public institutions, balance clinical efficacy with infection control and supply-chain resilience. Orthopedic clinics concentrate on specialized splinting options that support outpatient rehabilitation protocols. Recognizing these differences informs sales approaches, training programs, and product configuration choices.

Application-focused segmentation clarifies clinical demand drivers. Corrective casting requires materials and designs that support anatomical conformity and prolonged wear, fractures demand variable immobilization strategies depending on lower limb fractures or upper limb fractures, and postoperative immobilization stresses comfort, wound access, and compatibility with imaging. Understanding the nuances of each application enables manufacturers and providers to prioritize product attributes such as weight, breathability, adjustability, and radiolucency to maximize clinical fit and operational adoption.

A comparative view of how regional healthcare structures, procurement practices, and logistics realities determine product adoption, manufacturing localization, and go-to-market strategies

Regional differences materially influence product preference, regulatory pathways, and distribution models. The Americas present a heterogeneous environment where clinical practice patterns vary between tertiary hospital systems and ambulatory providers; procurement decisions often emphasize service integration, quality assurance, and contractual relationships with distributors. This region shows rising interest in synthetic and thermoplastic options that support rapid turnover and outpatient management, while also maintaining legacy plaster use in resource-constrained settings.

Europe, Middle East & Africa exhibit a complex mosaic of regulatory regimes and reimbursement structures that affect device uptake and clinical training investments. In some jurisdictions, centralized procurement encourages standardized solutions that simplify inventory management, whereas other jurisdictions place greater emphasis on clinician discretion and bespoke orthotic services. Economic diversity within the region drives both innovation opportunities and affordability pressures, so manufacturers must tailor commercialization strategies and regulatory support accordingly.

Asia-Pacific demonstrates varied adoption trajectories driven by demographic shifts, urbanization, and differential investment in surgical and rehabilitative care. Rapidly developing healthcare markets are primed for technologies that streamline care delivery and lower long-term costs, while established systems emphasize evidence-based selection and integration with electronic health records. Across these regions, supply-chain resilience and localization strategies have become central planning priorities due to trade policy shifts and logistics constraints, prompting region-specific manufacturing and distribution decisions to mitigate risk and support steady product availability.

How product innovation, clinical partnerships, manufacturing diversification, and value-driven positioning are defining competitive advantage for casting and splinting companies

Leading companies in casting and splinting are pursuing a combination of product innovation, clinical education, and distribution optimization. New material formulations and prefabricated splint designs reflect an emphasis on user-centered outcomes-lighter constructs, improved breathability, and compatibility with imaging modalities. Strategic partnerships between device firms and clinical networks have accelerated by focusing on training programs that shorten clinician learning curves and demonstrate time-savings in application.

Collaboration extends to supply-chain partnerships and contract manufacturing relationships that secure raw materials and flexible capacity. Firms that proactively diversified their supplier base or invested in regional manufacturing capacity reduced exposure to trade policy volatility and improved service levels. Meanwhile, companies enhancing digital tools for product selection, fitting support, and telehealth integration created differentiated value propositions for ambulatory and home-care settings. These integrated offerings strengthen distributor relationships and provide clinicians with decision-support resources that shorten procurement cycles.

Competitive positioning increasingly reflects a balance between commoditized offerings and higher-margin specialty products. Organizations that maintain strong clinical evidence, robust training, and responsive technical support tend to secure preferred-provider status within hospital systems and outpatient networks. As reimbursement models emphasize value and outcomes, companies that can demonstrate device contributions to lower complication rates, reduced readmissions, or shorter recovery timelines will maintain a distinct advantage in contracting conversations.

Concrete strategic moves for manufacturers, distributors, and providers to boost operational robustness, clinical uptake, and value-aligned commercial outcomes

Prioritize modular product families that allow clinicians to choose materials and application profiles suited to specific clinical pathways, enabling faster procurement approvals and streamlined inventory management. Invest in clinician-focused education programs that emphasize application efficiency, patient comfort, and outcomes-based use cases to shorten adoption cycles and reduce variability in application quality. Strengthening quality documentation and simplifying regulatory submissions will ease entry into diverse regional markets and reduce time-to-market for upgraded materials.

Develop supply-chain playbooks that include dual sourcing, nearshoring feasibility studies, and contract terms that mitigate tariff exposure. These measures reduce vulnerability to trade-policy shifts and logistics disruptions. Simultaneously, build commercial models that align pricing with clinical value rather than unit cost alone, demonstrating how device selection can reduce total care episodes, complications, or follow-up interventions. Finally, expand digital enablement tools-fitting guides, telehealth support, and post-application monitoring-to improve patient satisfaction and support longitudinal evidence generation that bolsters reimbursement conversations.

A transparent, practitioner-informed methodology integrating clinician interviews, technical literature, and supply-chain indicators to underpin actionable insights and validation

This analysis synthesizes primary and secondary inputs to produce a rounded, practitioner-focused assessment. Primary inputs included structured interviews with clinicians across acute, ambulatory, and home-care settings to capture real-world application preferences, procurement decision drivers, and training gaps. Secondary research incorporated technical literature on materials performance and regulatory guidance to validate clinical claims and to inform comparative assessments of product attributes.

Triangulation methods were applied to reconcile stakeholder perspectives with observable supply-chain indicators, such as supplier diversification trends, regional manufacturing announcements, and public policy changes affecting trade. Expert validation sessions ensured that emerging themes-material substitution, decentralization of care, and tariff-driven nearshoring-were robust against alternate interpretations. The resulting synthesis emphasizes actionable takeaways and practical frameworks for leaders considering investment, product development, or procurement changes.

A synthesis of clinical trends, supply-chain realities, and competitive imperatives to guide investment, product strategy, and operational decision-making in casting and splinting

The casting and splinting domain is at an inflection point where material science, clinical workflow changes, and trade-policy developments collectively reshape strategic choices. Clinicians and procurement leaders must weigh traditional techniques against innovations that promise better patient experience and operational efficiency, all while navigating a more complex supply environment. Companies that integrate clinician education, diversify supply chains, and deliver demonstrable value to health systems will be best positioned to influence purchasing decisions and sustain growth.

Moving forward, stakeholders should prioritize evidence generation, flexible manufacturing strategies, and customer-centric commercialization that addresses the needs of hospitals, ambulatory centers, home healthcare providers, and specialty clinics. By aligning product development with end-user workflows and regional logistics realities, organizations can reduce risk, accelerate adoption, and ensure that casting and splinting innovations translate into meaningful clinical and operational benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Casting & Splinting Market, by Product Type

  • 8.1. Fiberglass Casts
  • 8.2. Plaster Casts
  • 8.3. Splints
    • 8.3.1. Dynamic Splints
    • 8.3.2. Static Splints
  • 8.4. Synthetic Casts
  • 8.5. Thermoplastic Casts

9. Casting & Splinting Market, by Material

  • 9.1. Fiberglass
  • 9.2. Plaster Of Paris
  • 9.3. Thermoplastics
    • 9.3.1. High Temperature Thermoplastics
    • 9.3.2. Low Temperature Thermoplastics

10. Casting & Splinting Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals
  • 10.4. Orthopedic Clinics

11. Casting & Splinting Market, by Application

  • 11.1. Corrective Casting
  • 11.2. Fractures
    • 11.2.1. Lower Limb Fractures
    • 11.2.2. Upper Limb Fractures
  • 11.3. Post Operative Immobilization

12. Casting & Splinting Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Casting & Splinting Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Casting & Splinting Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Casting & Splinting Market

16. China Casting & Splinting Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. AliMed, Inc.
  • 17.7. Bird & Cronin, Inc.
  • 17.8. BSN Medical GmbH
  • 17.9. Cardinal Health, Inc.
  • 17.10. Corflex, Inc.
  • 17.11. DeRoyal Industries, Inc.
  • 17.12. DJO Global, Inc.
  • 17.13. Johnson & Johnson
  • 17.14. McKesson Corporation
  • 17.15. Medline Industries, LP
  • 17.16. Prime Medical, Inc.
  • 17.17. Smith & Nephew plc
  • 17.18. Zimmer Biomet Holdings, Inc.
  • 17.19. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CASTING & SPLINTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CASTING & SPLINTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 189. G7 CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 198. NATO CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NATO CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)